These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35680173)

  • 1. Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).
    Kharitonova T; Shvarts YG; Verbovoy AF; Orlova NS; Puzyreva VP; Strokov IA
    BMJ Open Diabetes Res Care; 2022 Jun; 10(3):. PubMed ID: 35680173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Oral Mixed Tocotrienols in Diabetic Peripheral Neuropathy: A Randomized Clinical Trial.
    ; Hor CP; Fung WY; Ang HA; Lim SC; Kam LY; Sim SW; Lim LH; Choon WY; Wong JW; Ch'ng ASH; Beh KKM; Wee HC; Ong LM; Khan NAK; Sulaiman SAS; Shuaib IL; Bakar A; Yusof Y; Yusof YM; Abu Bakar F; Tang WS; Teh HL; Wahid NA; Saaidin S; Idris N; Yoon CK; Ong HN; Ganapathy JT; Loo CE; Samy MM; Zainal H; Dharan SCS; Ooi BY; Teoh PY; Tye YL; Yeoh CA; Low DW; Looi I; Yuen KH
    JAMA Neurol; 2018 Apr; 75(4):444-452. PubMed ID: 29379943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
    Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
    Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
    Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.
    Shin S; Kim KJ; Chang HJ; Lee BW; Yang WI; Cha BS; Choi D
    Diabetes Obes Metab; 2013 Feb; 15(2):185-8. PubMed ID: 22974254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
    Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
    Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
    Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
    Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
    Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
    Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
    Ruhnau KJ; Meissner HP; Finn JR; Reljanovic M; Lobisch M; Schütte K; Nehrdich D; Tritschler HJ; Mehnert H; Ziegler D
    Diabet Med; 1999 Dec; 16(12):1040-3. PubMed ID: 10656234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
    Satoh J; Yagihashi S; Baba M; Suzuki M; Arakawa A; Yoshiyama T; Shoji S
    Diabet Med; 2011 Jan; 28(1):109-16. PubMed ID: 21166852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial.
    Won JC; Kwon HS; Moon SS; Chun SW; Kim CH; Park IB; Kim IJ; Lee J; Cha BY; Park TS
    Diabetes Metab J; 2020 Aug; 44(4):542-554. PubMed ID: 31701699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial.
    Pop-Busui R; Stevens MJ; Raffel DM; White EA; Mehta M; Plunkett CD; Brown MB; Feldman EL
    Diabetologia; 2013 Aug; 56(8):1835-44. PubMed ID: 23740194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial.
    Asadi S; Gholami MS; Siassi F; Qorbani M; Khamoshian K; Sotoudeh G
    Complement Ther Med; 2019 Apr; 43():253-260. PubMed ID: 30935539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy.
    Han Y; Wang M; Shen J; Zhang Z; Zhao M; Huang J; Chen Y; Chen Z; Hu Y; Wang Y
    Minerva Endocrinol; 2018 Mar; 43(1):11-18. PubMed ID: 27901334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
    Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
    Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial.
    Mosenzon O; Blicher TM; Rosenlund S; Eriksson JW; Heller S; Hels OH; Pratley R; Sathyapalan T; Desouza C;
    Lancet Diabetes Endocrinol; 2019 Jul; 7(7):515-527. PubMed ID: 31189517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.